Code of Practice for the Clinical Assessment of Licensed Medicinal Products in General Practice
Creator
Unknown authorBibliographic Citation
BMJ (British Medical Journal). 1983 Apr 16; 286(6373): 1295-1297.
Abstract
A code of practice for the clinical assessment of licensed drugs by physicians in general practice has been developed jointly by the British Medical Association, the Royal Society of General Practitioners, and the Association of the British Pharmaceutical Industry. The new code, reproduced in full here, outlines the reasons drug assessments outside hospitals are needed; defines the roles of pharmaceutical firms, ethics committees, and investigators; lists items that must be included in research protocols; and offers guidelines on confidentiality, publication of results, and remuneration. (KIE abstract)
Permanent Link
Find in a Libraryhttp://hdl.handle.net/10822/724030
Date
1983-04-16Subject
Clinical Ethics; Clinical Ethics Committees; Codes of Ethics; Confidentiality; Drug Industry; Drugs; Ethical Review; Ethics; Ethics Committees; Guidelines; General Practice; Hospitals; Human Experimentation; Industry; Investigators; Patient Care; Physicians; Pharmaceutical Industry; Remuneration; Research; Research Ethics; Review; Standards;
Publisher
British Medical Association; Royal College of General Practitioners; Association of the British Pharmaceutical Industry
Collections
Metadata
Show full item recordRelated items
Showing items related by title, author, creator and subject.
-
Code of Practice for the Clinical Assessment of Licensed Medicinal Products in General Practice
Unknown author (1983-04-16)